首頁 > 市場調查報告書 > 醫療設備

眼科設備

全球無晶體眼市場規模、佔有率及成長分析（按類型、最終用戶、治療方法和地區）- 產業預測（2025-2032）

市場調查報告書

商品編碼

1802012

全球無晶體眼市場規模、佔有率及成長分析（按類型、最終用戶、治療方法和地區）- 產業預測（2025-2032）

Aphakia Market Size, Share, and Growth Analysis, By Type (Acquired Aphakia, Congenital Aphakia), By End User (Hospitals, Ophthalmic clinics), By Treatment, By Region - Industry Forecast 2025-2032

出版日期: 2025年08月22日 | 出版商:

SkyQuest | 英文 184 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計 2023 年全球無晶體眼市場規模將達到 18 億美元，並從 2024 年的 20 億美元成長到 2032 年的 47.2 億美元，預測期內（2025-2032 年）的複合年成長率為 11.3%。

由於白內障患者數量不斷增加、老年人口不斷擴大以及眼外傷盛行率不斷上升，全球無晶體眼市場正在經歷顯著成長。事故和運動造成的眼外傷很普遍，通常會導致水晶體脫位，這進一步刺激了市場擴張。水晶體設計的創新增強了視力矯正效果，導致無晶體眼治療方法廣泛採用。此外，人們越來越意識到眼睛健康和早期療育的重要性，這正在推動市場需求。透過各種措施改善醫療保健的機會正在擴大治療機會。人工智慧、機器學習、物聯網、擴增實境(AR) 和虛擬實境 (VR) 等技術進步正在透過實現先進的病患監測、手術指導和增強的診斷能力來徹底改變市場，從而改善全球患者和醫療保健提供者的治療效果。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業市場定位（2024年）
主要市場參與者所採取的策略
近期市場趨勢
公司市場佔有率分析（2024年）
主要企業簡介
- 公司詳情
- 產品系列分析
- 按部門分類的公司佔有率分析
- 收益同比對比（2022-2024 年）

主要企業簡介

Johnson & Johnson Vision（Johnson & Johnson Services Inc.）
Alcon Laboratories Inc.
Carl Zeiss AG（ZEISS International）
Bausch+Lomb Incorporated
Rayner Intraocular Lenses Limited
Ophtec BV
CooperVision Inc.
Hoya Corporation
Menicon Co. Ltd.
Bohus BioTech AB
Lifecore Biomedical, LLC
Mediphacos
Santen Pharmaceutical Co. Ltd.
UltraVision CLPL

結論和建議

簡介目錄

Product Code: SQMIG35A3108

Global Aphakia Market size was valued at USD 1.8 billion in 2023 and is poised to grow from USD 2.0 billion in 2024 to USD 4.72 billion by 2032, growing at a CAGR of 11.3% during the forecast period (2025-2032).

The global aphakia market is experiencing significant growth due to a rise in cataract cases, an increasing aging population, and a heightened incidence of eye trauma. The prevalence of eye injuries from accidents and sports often results in lens dislocation, further driving market expansion. Innovations in lens design enhance visual correction, leading to greater adoption of aphakia treatments. Moreover, heightened awareness about eye health and the importance of early intervention boosts market demand. Improved healthcare access through various initiatives fosters widespread treatment opportunities. Technological advancements, including AI, machine learning, IoT, augmented reality, and virtual reality, are revolutionizing the market by enabling sophisticated patient monitoring, surgical guidance, and enhanced diagnostic capabilities, thereby improving outcomes for both patients and healthcare providers globally.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Aphakia market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Aphakia Market Segments Analysis

Global Aphakia Market is segmented by Type, End User, Treatment and region. Based on Type, the market is segmented into Acquired Aphakia and Congenital Aphakia. Based on End User, the market is segmented into Hospitals, Ophthalmic clinics and Others. Based on Treatment, the market is segmented into Spectacles, Contact Lenses, Intraocular Lens Implantation and Refractive Surgery. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Aphakia Market

The global aphakia market is significantly driven by the rising demand for cataract surgeries, which involve the removal of the natural lens from the eye, creating avenues for effective aphakia treatments. As more healthcare professionals prefer surgeries for high-risk cataract patients, the market experiences enhanced growth potential. Furthermore, regions with improved healthcare access are witnessing a surge in aphakia cases, further propelling market expansion. This combination of surgical advancements and increased patient accessibility underscores the robust opportunities for innovation and investment within the aphakia treatment sector on a global scale.

Restraints in the Global Aphakia Market

The global aphakia market faces significant constraints primarily due to the high costs associated with treatment options. Interventions typically involve the use of intraocular lenses, specialized contact lenses, or intricate surgical procedures, all of which can be prohibitively expensive. This financial burden limits access and hinders the adoption of effective therapies for those affected by aphakia. Furthermore, manufacturers encounter difficulties in balancing affordability with the necessary standards of precision and safety, which further complicates efforts to enhance market availability and treatment accessibility. Consequently, these factors collectively contribute to the restricted growth of the aphakia treatment market.

Market Trends of the Global Aphakia Market

The Global Aphakia market is witnessing a significant trend driven by the escalating demand for intraocular lenses (IOLs) as patients and ophthalmologists increasingly recognize their advantages in correcting vision. This surge is further propelled by a broader shift towards minimally invasive surgical techniques, which enhance patient comfort and recovery. As advancements in IOL technology continue to emerge, offering improved visual outcomes and reduced complications, more individuals are opting for these solutions post-cataract surgery. The combination of heightened awareness, technological innovations, and a preference for efficient surgical processes is collectively fostering a robust growth trajectory in the Global Aphakia market.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Studies

Global Aphakia Market Size by Type & CAGR (2025-2032)

Market Overview
Acquired Aphakia
Congenital Aphakia

Global Aphakia Market Size by End User & CAGR (2025-2032)

Market Overview
Hospitals
Ophthalmic clinics
Others

Global Aphakia Market Size by Treatment & CAGR (2025-2032)

Market Overview
Spectacles
Contact Lenses
Intraocular Lens Implantation
Refractive Surgery

Global Aphakia Market Size & CAGR (2025-2032)

North America (Type, End User, Treatment)
- US
- Canada
Europe (Type, End User, Treatment)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, End User, Treatment)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, End User, Treatment)
- Brazil
- Rest of Latin America
Middle East & Africa (Type, End User, Treatment)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Johnson & Johnson Vision (Johnson & Johnson Services Inc.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alcon Laboratories Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Carl Zeiss AG (ZEISS International)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bausch + Lomb Incorporated
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Rayner Intraocular Lenses Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ophtec BV
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CooperVision Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hoya Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Menicon Co. Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bohus BioTech AB
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lifecore Biomedical, LLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mediphacos
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Santen Pharmaceutical Co. Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
UltraVision CLPL
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments